Literature DB >> 20396981

Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.

Parvin Mehdipour1, Marzieh Mahdavi, Javad Mohammadi-Asl, Morteza Atri.   

Abstract

The involvement of ATM gene and specifically, the important role of D1853N polymorphism, as a three-hit hypothesis has been previously reported in an Iranian proband affected with brain tumor and this polymorphism could be screened in her relatives as well. The aim of present study was to investigate the involvement of D1853N polymorphism as a predisposition factor in 129 Iranian patients affected with primary breast cancer and 248 sex- and age-matched healthy controls. Mutant allele-specific PCR amplification (MASA) assay was performed to analyze the D1853N polymorphism in the ATM gene. The frequency of D1853N polymorphism in cases, internal and external controls was 31.0% (40/129), 26.9% (28/104) and 12.5% (18/144), respectively. The frequency of D1853N in total control groups, including normal external control and pedigree internal control, was 18.6% (46/248). The odds ratio was calculated with the logistic regression test, with an estimated relative risk of 2.579 (P=0.005). The significant difference was observed between the patient-carriers of this alteration and external controls (P=0.001). The number of controls harboring D1853N polymorphism was higher in internal control compared to external controls, and the difference was statistically significant (P=0.004). The significant difference was observed between the patient-carriers and external controls and could be considered as a predisposing and diagnostic marker in the population and specifically in the cancer-prone pedigrees.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20396981     DOI: 10.1007/s12032-010-9525-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  20 in total

1.  Heterozygous ATM mutations do not contribute to early onset of breast cancer.

Authors:  M G FitzGerald; J M Bean; S R Hegde; H Unsal; D J MacDonald; D P Harkin; D M Finkelstein; K J Isselbacher; D A Haber
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

2.  ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.

Authors:  A Broeks; J H Urbanus; A N Floore; E C Dahler; J G Klijn; E J Rutgers; P Devilee; N S Russell; F E van Leeuwen; L J van 't Veer
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.

Authors:  K Laake; V Launonen; D Niederacher; S Gudlaugsdottir; S Seitz; P Rio; M H Champème; I Bièche; D Birnbaum; G White; M Sztan; N Sever; S Plummer; A Osorio; A Broeks; P Huusko; N Spurr; A Borg; A M Cleton-Jansen; L van't Veer; J Benitez; G Casey; B Peterlin; E Olah; A L Børresen-Dale
Journal:  Genes Chromosomes Cancer       Date:  1999-07       Impact factor: 5.006

4.  Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.

Authors:  S Stilgenbauer; C Schaffner; A Litterst; P Liebisch; S Gilad; A Bar-Shira; M R James; P Lichter; H Döhner
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

5.  Cancer incidence and mortality in Iran.

Authors:  S M Mousavi; M M Gouya; R Ramazani; M Davanlou; N Hajsadeghi; Z Seddighi
Journal:  Ann Oncol       Date:  2008-12-10       Impact factor: 32.976

6.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families.

Authors:  N Sandoval; M Platzer; A Rosenthal; T Dörk; R Bendix; B Skawran; M Stuhrmann; R D Wegner; K Sperling; S Banin; Y Shiloh; A Baumer; U Bernthaler; H Sennefelder; M Brohm; B H Weber; D Schindler
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 8.  Cancer risks in A-T heterozygotes.

Authors:  D F Easton
Journal:  Int J Radiat Biol       Date:  1994-12       Impact factor: 2.694

9.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Authors:  M Negrini; D Rasio; G M Hampton; S Sabbioni; S Rattan; S L Carter; A L Rosenberg; G F Schwartz; Y Shiloh; W K Cavenee
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

10.  Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehr-Azin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-01-14       Impact factor: 3.064

View more
  10 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

3.  The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Lin-Bo Gao; Xin-Min Pan; Hong Sun; Xia Wang; Li Rao; Li-Juan Li; Wei-Bo Liang; Mei-Li Lv; Wen-Zhong Yang; Lin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2010-08-27

Review 4.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

5.  Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy.

Authors:  Karolina Tecza; Jolanta Pamula-Pilat; Zofia Kolosza; Natalia Radlak; Ewa Grzybowska
Journal:  J Exp Clin Cancer Res       Date:  2015-01-16

6.  Genetic determinants of sporadic breast cancer in Sri Lankan women.

Authors:  Nirmala Dushyanthi Sirisena; Adebowale Adeyemo; Anchala I Kuruppu; Nilaksha Neththikumara; Nilakshi Samaranayake; Vajira H W Dissanayake
Journal:  BMC Cancer       Date:  2018-02-13       Impact factor: 4.430

7.  ATM in breast and brain tumors: a comprehensive review.

Authors:  Mehrdad Asghari Estiar; Parvin Mehdipour
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

8.  Diversity in tumor territory of meningioma: Protein expression in vascular endothelial growth factor and epidermal growth factor.

Authors:  Parvin Mehdipour; Firoozeh Javan; Morteza Faghih-Jouibari; Mehdi Khaleghi
Journal:  Iran J Neurol       Date:  2019-04-04

Review 9.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

10.  Evolutionary model of brain tumor circulating cells: Cellular galaxy.

Authors:  Parvin Mehdipour; Firoozeh Javan; Morteza Faghih Jouibari; Mehdi Khaleghi; Masoud Mehrazin
Journal:  World J Clin Oncol       Date:  2021-01-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.